文献速递肝病消化道出血

肝硬化中的止血:理解急性失代偿期间的不稳定因素

Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation.
PubMed 文献 · J Hepatol · 2023-01-25

综述阐述住院肝硬化失代偿患者因促凝血与抗凝血通路平行下降而处于再平衡止血状态,但该状态易受急性肾损伤、细菌感染/脓毒症及慢加急性肝衰竭影响而倾向低凝与出血,目前无单一实验室方法能准确分层出血风险。

要点

  • 失代偿肝硬化患者止血再平衡状态易被急性肾损伤、感染/脓毒症及慢加急性肝衰竭打破。
  • 上述急性事件与特定止血通路额外改变及更高出血风险相关。
  • 尚无单一实验室方法能准确分层个体出血风险并指导操作前预防。

核心结论

  • 住院失代偿肝硬化患者处于再平衡止血状态,但易受扰动而倾向低凝与出血。
  • 更好理解急性疾病期间的止血改变可带来更合理和个体化的管理。

研究设计与样本

  • 综述,汇总急性肾损伤、细菌感染/脓毒症及慢加急性肝衰竭驱动止血改变的最新发现。

主要发现

  • 失代偿肝硬化患者促凝血与抗凝血通路平行下降导致再平衡止血状态。
  • 急性肾损伤、细菌感染/脓毒症及从急性失代偿进展为慢加急性肝衰竭与特定止血通路额外改变及更高出血风险相关。
  • 无单一实验室方法能准确分层个体患者出血风险并指导操作前预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state due to a parallel decline in both pro- and anti-haemostatic pathways. However, this rebalanced haemostatic state is highly susceptible to perturbations and may easily tilt towards hypocoagulability and bleeding. Acute kidney injury, bacterial infections and sepsis, and progression from acute decompensation to acute-on-chronic liver failure are associated with additional alterations of specific haemostatic pathways and a higher risk of bleeding. Unfortunately, there is no single laboratory method that can accurately stratify an individual patient's bleeding risk and guide pre-procedural prophylaxis. A better understanding of haemostatic alterations during acute illness would lead to more rational and individualised management of hospitalised patients with decompensated cirrhosis. This review will outline the latest findings on haemostatic alterations driven by acute kidney injury, bacterial infections/sepsis, and acute-on-chronic liver failure in these difficult-to-treat patients and provide evidence supporting more tailored management of bleeding risk.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Zanetto A, Northup P, Roberts L, et al. Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation. J Hepatol. 2023. PMID: 36708812. doi:10.1016/j.jhep.2023.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。